Menu ×


Expanded Hemodialysis Therapy Market Segmentation by Product (Machines, Dialyzers, Concentrates, Dialysates, and Catheters); by Modality (Short Daily, Conventional Long-Term, and Nocturnal); by End User (Hospital, Independent Dialysis, and Home Dialysis) – Global Demand Analysis & Opportunity Outlook 2030

  • Text Size:

Extensive insights into the Growth of Expanded Hemodialysis Therapy Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More


  • August 31, 2020: Baxter announced that the U.S. Food and Drug Administration (FDA) granted the De Novo authorization for Thernova dialyzers, which are offer expanded hemodialysis therapy to patients with kidney failure.  

Global Expanded Hemodialysis Therapy Market Highlights 2022 – 2030

The global expanded hemodialysis therapy market is estimated to garner a large revenue by recording a CAGR of ~6% over the forecast period, i.e., 2022 – 2030. The growth of the market can be attributed to the increasing prevalence of hypertension and diabetes, growing number of patients of end-stage renal disease (ESRD), and rising technological advancements associated with developing innovative therapies. According to the International Diabetes Foundation, in 2020, about 463 million adults aged between 20 to 79 years were living with diabetes, the population of which is calculated to rise up to 700 million by 2045. Along with these, escalating number of dialysis centers and rise in preference for expanded hemodialysis therapy among patients are also projected to drive market growth in the near future. Furthermore, growing shortage of organ donors and emerging markets in developing regions are expected to offer ample growth opportunities to the market in the upcoming years. CLICK TO DOWNLOAD SAMPLE REPORT



The market is segmented by modality into short daily, conventional long-term, and nocturnal, out of which, the conventional long-term segment is anticipated to hold the largest share in the global expanded hemodialysis therapy market on account of the high acceptance of expanded hemodialysis therapy among patients suffering from chronic kidney disease and ESRD. In addition, growing focus of prominent manufacturers on developing advanced dialysis equipment is also predicted to boost the growth of the market segment by the end of 2030. Moreover, on the basis of end user, the segment for independent dialysis is projected to occupy the largest share over the forecast period owing to the growing number of dialysis centers across the globe and rising availability of skilled healthcare professionals in dialysis centers.

Major Macro-Economic Indicators Impacting the Market Growth


According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Expanded Hemodialysis Therapy Market Regional Synopsis

On the basis of geographical analysis, the global expanded hemodialysis therapy market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. The market in the Asia Pacific is estimated to witness noteworthy growth over the forecast period on the back of rising per capita income, increasing government initiatives supporting the usage of advanced medical therapies and significant improvements in healthcare infrastructure. Apart from these, growing geriatric population is also assessed to drive market growth in the region. Additionally, the market in North America is projected to grab the largest market share during the forecast period owing to the high healthcare spending, increasing occurrence of chronic kidney diseases and strong presence of market players in the region. As per the United States Centers for Disease Control and Prevention, more than 1 in 7, that is 37 million people or 15 percent of the country’s total population is estimated to have chronic kidney disease.

The global expanded hemodialysis therapy market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Market Segmentation

Our in-depth analysis of the global expanded hemodialysis therapy market includes the following segments:

By Product

  • Machines
  • Dialyzers
  • Concentrates
  • Dialysates
  • Catheters

By Modality

  • Short Daily
  • Conventional Long-Term
  • Nocturnal

By End User

  • Hospital
  • Independent Dialysis
  • Home Dialysis

Growth Drivers

  • Growing Prevalence of Diabetes and Hypertension
  • Increasing Technological Advancements to Develop Innovative Therapies


  • Complications and Risks Associated with Dialysis

Top Featured Companies Dominating the Market

  • B. Braun Melsungen AG
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Asahi Kasei Corporation
  • Baxter International, Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Nikkiso Co., Ltd.
  • Nipro Corporation
  • NxStage Medical, Inc.
  • Cantel Medical Corp.
  • Satellite Healthcare, Inc.



Related Reports

Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved